Back to mobile site

Regeneron Pharma (REGN) PT Raised to $475 at Cowen

May 4, 2017 3:39 PM EDT Send to a Friend
Cowen raised its price target on Regeneron Pharma (NASDAQ: REGN) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login